PI3K Inhibitors Curtail MYC-Dependent Mutant p53 Gain-of-Function in Head and Neck Squamous Cell Carcinoma.

导出原文传递

翻译打印收藏纠错

第一作者： Federica,Ganci

第一单位： Oncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.

作者： Federica,Ganci ^[1] ; Claudio,Pulito ^[1] ; Sara,Valsoni ^[2] ; Andrea,Sacconi ^[1] ; Chiara,Turco ^[1] ; Mahrou,Vahabi ^[1] ; Valentina,Manciocco ^[3] ; Emilia Maria Cristina,Mazza ^[2] ; Jalna,Meens ^[4] ; Christina,Karamboulas ^[4] ; Anthony C,Nichols ^[5] ; Renato,Covello ^[6] ; Raul,Pellini ^[3] ; Giuseppe,Spriano ^[3] ; Giuseppe,Sanguineti ^[7] ; Paola,Muti ^[8] ; Silvio,Bicciato ^[9] ; Laurie,Ailles ^[2] ; Sabrina,Strano ^[5] ; Giulia,Fontemaggi ^[1] ; Giovanni,Blandino ^[10]

作者单位： Oncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. ^[1] Department of Life Sciences, Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy. ^[2] Otolaryngology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. ^[3] Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. ^[4] Department of Otolaryngology-Head and Neck Surgery, Western University, London, Ontario, Canada. ^[5] Department of Pathology, IRCCS Regina Elena National Cancer Institute, Rome, Italy. ^[6] Radiation Oncology Department, IRCCS Regina Elena National Cancer Institute, Rome, Italy. ^[7] Department of Oncology, Juravinski Cancer Center-McMaster University Hamilton, Ontario, Canada. ^[8] Department of Biomedical, Surgical and Dental Sciences, University of Milan La Statale, Milan, Italy. ^[9] Oncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. giovanni.blandino@ifo.gov.it giulia.fontemaggi@ifo.gov.it. ^[10]